Cullimore

Ian Henry Stuart Cullimore, Leominster GB

Patent application number	Description	Published
20110107357	TCP/IP Stack-Based Operating System - Systems and corresponding methods include a system having an operating system based wholly around a protocol stack, such as a Transmission Control Protocol/Internet Protocol (TCP/IP) stack. The system may include a central processing unit (CPU) including the operating system embedded therein, and a network interface coupled with a network and the CPU. The network may be the Internet. The operating system is fundamentally a state machine. The kernel of the operating system is fundamentally just a protocol stack for communicating with one or more devices of the network via the network interface. The protocol stack may be a TCP/IP protocol stack, UDP/IP stack or combinations thereof. A chip may be provided that includes the TCP/IP stack state machine-based operating system embedded in a CPU. The resultant chip may be ultra low power, miniscule in size, and IP-centric.	05-05-2011

Patent application number	Description	Published
20090163140	Biochip electroporator and its use in multi-site, single-cell electroporation - A remote access and control system for remotely controlling a wide variety of devices using an application installed in a cell phone in conjunction with a control module in communication with the cell phone and the device(s). A portal-based access and control system is also disclosed.	06-25-2009

Patent application number	Description	Published
20080268515	Method and apparatus for production and refinement of microbial consortia for the generation of selective therapeutic chemical agents - A culturing fluid of defined bacterial consortia is placed within a cultivation apparatus to generate growths of either a bioconcretious or biocolloidal form within, or attached to surfaces exposed to, the culturing fluid. Such growths involve the interactive activities between all of the bacterial consortia to generate growths and economically attractive chemical daughter and end products within the fluid environment bounded by the cultivation apparatus. The cultivation apparatus allows the culturing fluid to flow along passageways that have alternating constricted and expanded zones in a manner that creates the growth of bioconcretious or biocolloidal structures within which the bacterial consortia interact to allow maintenance of these growth structures and stimulate the production of the desired chemical products of significance. The bacterial consortia generate either biocolloids or bioconcretions within an electrically charged field that is generated by the interaction of the consortia with dissimilar metal or carbon surfaces of the passageways. The grown interacting bacterial consortia and their culturing fluids can be used as sources of chemicals such as therapeutic agents that are anti-microbial, probiotic, anti-biotic, or anti-cancer agents.	10-30-2008